The pyridine analogue of thiamine, 2-methyl4 amino-5-pyrimidyl-methyl-(2-methyl-3-j3hydroxyethyl) pyridinium bromide, has been reported by Robbins (1941) Using Staphylococcus aureus, an organism requiring thiamine for growth, the amount of thiamine necessary to restore growth to one-half the maximum rate in the presence of varied pyrithiamine concentrations was determined (table 1) . The organisms were grown in a chemically defined medium and the growth was followed by turbidity measurements.
The relative activity as shown by the inhibitor-growth factor ratio is roughly comparable to that of sulfapyridine in the p-aminobenzoic acid inhibition when tested under similar conditions. Like the sulfonamides, pyrithiamine also inhibits those organisms which do not require the growth factor analogue to be added to the culture medium. The inhibitor-growth factor ratio with Escherichia coli is less favorable for the antagonist than is the case with the thiamine-requiring staphylococcus, but a definite competition exists (table 2.) In the case of both organisms, by using sufficient thiamine, growth can be restored to the control level even in the presence of large amounts of pyrithiamine.
Pyrithiamine has been injected into mice but concentrations non-injurious to the animals failed to produce antibacterial concentrations in the blood. It shows, therefore, little promise as a systemic chemotherapeutic agent.
